|
MFAP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.500500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.658840E-01 |
| Normal-vs-Stage2 |
1.872290E-02 |
| Normal-vs-Stage3 |
3.791700E-02 |
| Normal-vs-Stage4 |
1.288060E-02 |
| Stage1-vs-Stage2 |
2.090000E-01 |
| Stage1-vs-Stage3 |
2.046600E-01 |
| Stage1-vs-Stage4 |
3.343600E-01 |
| Stage2-vs-Stage3 |
8.502000E-01 |
| Stage2-vs-Stage4 |
7.231800E-01 |
| Stage3-vs-Stage4 |
9.029200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.582100E-02 |
| Normal-vs-AfricanAmerican |
1.295760E-01 |
| Normal-vs-Asian |
4.588000E-01 |
| Caucasian-vs-AfricanAmerican |
8.858800E-01 |
| Caucasian-vs-Asian |
8.095400E-01 |
| AfricanAmerican-vs-Asian |
7.076400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.470050E-02 |
| Normal-vs-Female |
8.906000E-01 |
| Male-vs-Female |
5.185800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.973700E-02 |
| Normal-vs-Extreme_Weight |
4.836000E-02 |
| Normal-vs-Obese |
2.626800E-01 |
| Normal-vs-Extreme_Obese |
1.777370E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.870600E-01 |
| Normal_Weight-vs-Obese |
3.818200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.695800E-01 |
| Extreme_Weight-vs-Obese |
4.788400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.456200E-01 |
| Obese-vs-Extreme_Obese |
3.987200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.282200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.185600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.603800E-02 |
| Normal-vs-Age(81-100Yrs) |
2.746300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.202800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.403800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.641600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.197800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.365500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.122000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.395000E-01 |
| Normal-VS-Type2 PRCC |
9.798800E-04 |
| Normal-VS-KIRP CIMP |
2.998100E-03 |
| Normal-VS-Unclassified PRCC |
2.215200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.255200E-03 |
| Type1 PRCC-VS-KIRP CIMP |
7.267800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.157000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.356600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.294600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.720800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.751700E-04 |
| Normal-vs-N1 |
9.856300E-03 |
| Normal-vs-N2 |
3.774100E-02 |
| N0-vs-N1 |
9.730000E-01 |
| N0-vs-N2 |
8.222000E-01 |
| N1-vs-N2 |
8.483600E-01 |
|
|
